Advanced International Journal for Research

E-ISSN: 3048-7641   •   Impact Factor: 9.11

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 7, Issue 5 (September-October 2026) Submit your research before last 3 days of October to publish your research paper in the issue of September-October.

“Vulval Fibroid” in India: Understanding Vulvar Leiomyoma—Biology, Barriers, and Better Pathways of Care

Author(s) Dr. Riti Agarwal
Country India
Abstract Background: “Vulval fibroid” is the lay term most Indians would use for vulvar leiomyoma—a rare, benign smooth-muscle tumor of the vulva that is frequently misdiagnosed as a Bartholin cyst or other vulvar mass. Despite hundreds of thousands of Indian women presenting with vulvar complaints each year, true epidemiology of vulvar leiomyoma remains poorly characterized, with knowledge dominated by case reports and small series. (PMC, ClinMed Journals)
Objective: To synthesize global and Indian evidence on vulvar leiomyoma (henceforth, “vulval fibroid”) and translate it into pragmatic, culturally sensitive recommendations for clinicians, health-system planners, and communities in India.
Methods: We searched peer-reviewed journals (PubMed/PMC), professional guidelines (ISSVD, ACOG), government policy documents (MoHFW, NACO; Ayushman Bharat), press releases, and credible educational media (podcasts/YouTube). Inclusion prioritized 2020–2025 publications and India-specific sources; older, foundational studies were retained when necessary for rare entities and classification schemes. (PMC, NACO, Ministry of Health and Family Welfare, Apple Podcasts)
Key findings:
1. Biology/diagnosis: Vulval fibroids are ER/PR-positive smooth-muscle tumors; imaging (transperineal ultrasound → MRI) and histology/IHC (desmin, SMA, h-caldesmon) distinguish them from Bartholin lesions and other mesenchymal tumors. Surgical excision with clear margins is curative in most cases; recurrence is uncommon but reported. (ScienceDirect, PMC)
2. Sociocultural: Indian women face stigma, modesty concerns, and limited female providers, contributing to care-seeking delays—especially in rural areas and among adolescents. (PMC)
3. System response: India’s Ayushman Arogya Mandirs and eSanjeevani telemedicine network are rapidly scaling access; standardized RTI/STI services (Suraksha Clinics) offer a ready gateway for vulvar complaints, yet vulvar-specific pathways are underdeveloped. (Ministry of Health and Family Welfare, Ministry of Health and Family Welfare, NACO)
4. Solutions: A tiered vulvar-mass pathway anchored in transperineal ultrasound at primary care, point-to-specialist tele-referral, and definitive day-care excision (AB-PM-JAY/state packages such as labial cyst excision) is feasible and culturally acceptable. (PMC, Jeevandayee)
Conclusions: Vulval fibroid is uncommon but important. An India-appropriate pathway emphasizing respectful examination, ultrasound triage, and timely excision with pathology can reduce delays and misdiagnosis while leveraging national digital health assets.
Keywords vulvar leiomyoma; vulval fibroid; transperineal ultrasound; India; Bartholin cyst; Ayushman Bharat.
Field Medical / Pharmacy
Published In Volume 7, Issue 5, September-October 2026
Published On 2026-10-12

Share this